NICOLE PALM: Open Payments
NPI 1497168330 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,203 in 78 payments from 20 companies in 2025. Trend: 2023 $986 · 2024 $1,427 · 2025 $2,203
Food & beverage: $2,203
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $409 |
| Novo Nordisk Inc | 9 | $388 |
| Amgen Inc. | 2 | $260 |
| AstraZeneca Pharmaceuticals LP | 13 | $233 |
| PFIZER INC. | 8 | $198 |
| Braeburn Inc. | 7 | $196 |
| Lilly USA, LLC | 6 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $64 |
| Exact Sciences Corporation | 3 | $59 |
| Esperion Therapeutics, Inc. | 2 | $44 |
Products named: REPATHA, BRIXADI, VRAYLAR, AIRSUPRA, Wegovy, Ozempic, NURTEC ODT, QULIPTA.
Industry payments across FL — which companies pay providers there.
